Dr. Zhonglin Hao
Claim this profileUniversity of Kentucky/Markey Cancer Center
Area of expertise
Small Cell Lung Cancer
Zhonglin Hao has run 5 trials for Small Cell Lung Cancer.
Lung Cancer
Zhonglin Hao has run 4 trials for Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of Kentucky/Markey Cancer Center
University Of Kentucky
Clinical Trials Zhonglin Hao is currently running
ONC-392 vs Chemotherapy
for Lung Cancer
This trial is testing gotistobart, a new drug that helps the immune system fight advanced lung cancer in patients who haven't responded to other treatments. It works by blocking a protein that allows cancer cells to hide from the immune system.
Recruiting
2 awards
Phase 3
10 criteria
Tazemetostat + Topotecan + Pembrolizumab
for Small Cell Lung Cancer
This phase I trial tests the safety, side effects, and best dose of tazemetostat in combination with topotecan and pembrolizumab in treating patients with small cell lung cancer that has come back after a period of improvement (recurrent). Tazemetostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as topotecan, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving tazemetostat in combination with topotecan and pembrolizumab may shrink or stabilize recurrent small cell lung cancer.
Recruiting
1 award
Phase 1
19 criteria
More about Zhonglin Hao
Clinical Trial Related
6 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Zhonglin Hao has experience with
- Durvalumab
- Topotecan Hydrochloride
- Atezolizumab
- Copanlisib
- Docetaxel
- ONC-392
Breakdown of trials Zhonglin Hao has run
Small Cell Lung Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Colon Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Zhonglin Hao specialize in?
Zhonglin Hao focuses on Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Small Cell Lung Cancer has involved treating patients, or patients who are undergoing treatment.
Is Zhonglin Hao currently recruiting for clinical trials?
Yes, Zhonglin Hao is currently recruiting for 4 clinical trials in Lexington Kentucky. If you're interested in participating, you should apply.
Are there any treatments that Zhonglin Hao has studied deeply?
Yes, Zhonglin Hao has studied treatments such as Durvalumab, Topotecan Hydrochloride, Atezolizumab.
What is the best way to schedule an appointment with Zhonglin Hao?
Apply for one of the trials that Zhonglin Hao is conducting.
What is the office address of Zhonglin Hao?
The office of Zhonglin Hao is located at: University of Kentucky/Markey Cancer Center, Lexington, Kentucky 40536 United States. This is the address for their practice at the University of Kentucky/Markey Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.